ARK Invest, the investment firm led by Cathie Wood, bought shares of Rocket Lab on Thursday, even as the space company announced a delay to the first launch of its reusable Neutron rocket. The stock fell 6.6% on the news, but ARK's exchange-traded funds (ETFs) added to their positions, signaling confidence in the company's long-term prospects.
Why the delay?
Rocket Lab said the slip comes from the factory floor. CEO Peter Beck said on Wednesday that the company discovered a manufacturing issue with the rocket's "forward dome," paused work, and started investigating. The forward dome is a key structural component of the rocket, and any flaw there could compromise safety or performance.
This is not the first time Rocket Lab has adjusted its timeline for Neutron. The company has been developing the rocket for years, and delays are common in the aerospace industry, where testing and safety requirements are stringent. However, each postponement pushes back the potential revenue stream from Neutron, which is designed to compete in the growing market for medium-lift launch services.
What Neutron means for Rocket Lab
Neutron is Rocket Lab's next big growth bet. The company's current workhorse, the Electron rocket, is a small-lift vehicle that has carved out a niche for launching small satellites. But Neutron is a larger, reusable rocket aimed at bigger payloads and more frequent launches, which could open up new markets and significantly increase revenue.
The delay to 2027 means investors will have to wait longer for that new revenue to materialize. In the meantime, Rocket Lab continues to generate income from its existing launch services and its space systems division, which builds satellite components and spacecraft. The company has also been expanding its capabilities, including work on a spacecraft for NASA and other government contracts.
Why ARK is buying
ARK Invest is known for investing in disruptive, high-growth companies, often in technology and space. Cathie Wood has been a vocal advocate for space exploration and commercialization, and Rocket Lab fits that theme. The purchase on Thursday suggests ARK sees the Neutron delay as a temporary setback rather than a fundamental problem.
ARK's move also reflects a broader strategy: buying on dips. When a stock falls on bad news, ARK sometimes sees it as an opportunity to accumulate shares at a lower price. This approach is common among growth investors who focus on long-term potential rather than short-term fluctuations.
What it means for investors
For everyday investors, the key takeaway is that Rocket Lab's stock is volatile, and delays like this can cause sharp swings. The company is still in its growth phase, and its success depends on executing its plans for Neutron and other projects. While ARK's purchase may signal confidence, it's not a guarantee of future performance.
Investors should also consider the broader context. The space industry is competitive, with players like SpaceX dominating the market. Rocket Lab has carved out a niche, but it faces challenges from both established companies and new entrants. The delay to Neutron gives competitors more time to solidify their positions.
If you're considering investing in Rocket Lab, it's important to weigh the potential rewards against the risks. The company has a strong track record with Electron and a growing pipeline of contracts, but the road to profitability is still long. As always, diversification is key—don't put all your eggs in one basket, especially in a high-risk sector like space.
Looking ahead
Investors will be watching for updates on the Neutron investigation and any revised timeline. Rocket Lab has not provided a new specific launch date beyond 2027, so clarity on that front could be a catalyst for the stock. In the meantime, the company's quarterly earnings reports will offer insights into its financial health and progress on other initiatives.
For those interested in the space sector, Rocket Lab is one of the few publicly traded pure-play options. But as this week's events show, investing in space comes with its own set of risks. Stay informed, and consider how this fits into your overall investment strategy.
Related: Rocket Lab's stock slide and premarket moves.
